I don't think you should write off all juniors, but ones with clear issues with production or clear barriers to ever starting should be avoided. Clearly IO is out of favour.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025